Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Synthetic Vasopressin Nasal Spray in the Treatment of Diabetes Insipidus

Synthetic Vasopressin Nasal Spray in the Treatment of Diabetes Insipidus THE LONG-TERM treatment of vasopressinsensitive diabetes insipidus remains a complex and challenging problem. Vasopressin is available for therapy as an oil-repository material, vasopressin tannate injection (Pitressin Tannate in oil), in aqueous solution, vasopressin injection (Pitressin), and in powder form administered by nasal insufflation, posterior pituitary powder. These forms have certain drawbacks and more convenient therapeutic materials are desirable. Recently, the use of synthetic lysine vasopressin, lysyl-8-vasopressin, as a nasal spray has been studied.1-3 We wish to report our experience to date with this material in 19 patients with vasopressinsensitive diabetes insipidus. Antidiuretic hormone (ADH) levels and disappearance curves in blood have been studied in three patients4; clinical response to the medication is reported here. Methods Lysyl-8-vasopressin spray was provided in 5 ml (50 IU per milliliter) squeeze bottle containers. Two lines of investigation were followed. In the first, three patients (cases 3, 10, and 11) were studied in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Synthetic Vasopressin Nasal Spray in the Treatment of Diabetes Insipidus

Loading next page...
 
/lp/american-medical-association/synthetic-vasopressin-nasal-spray-in-the-treatment-of-diabetes-2PzXGPEsvT

References (2)

Publisher
American Medical Association
Copyright
Copyright © 1964 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1964.03070250051019
Publisher site
See Article on Publisher Site

Abstract

THE LONG-TERM treatment of vasopressinsensitive diabetes insipidus remains a complex and challenging problem. Vasopressin is available for therapy as an oil-repository material, vasopressin tannate injection (Pitressin Tannate in oil), in aqueous solution, vasopressin injection (Pitressin), and in powder form administered by nasal insufflation, posterior pituitary powder. These forms have certain drawbacks and more convenient therapeutic materials are desirable. Recently, the use of synthetic lysine vasopressin, lysyl-8-vasopressin, as a nasal spray has been studied.1-3 We wish to report our experience to date with this material in 19 patients with vasopressinsensitive diabetes insipidus. Antidiuretic hormone (ADH) levels and disappearance curves in blood have been studied in three patients4; clinical response to the medication is reported here. Methods Lysyl-8-vasopressin spray was provided in 5 ml (50 IU per milliliter) squeeze bottle containers. Two lines of investigation were followed. In the first, three patients (cases 3, 10, and 11) were studied in

Journal

JAMAAmerican Medical Association

Published: Dec 21, 1964

There are no references for this article.